Skip to search formSkip to main contentSkip to account menu

lipoxin A4

Known as: 5,6,15-triHETE, LXA4, 5,6,15-trihydroxy-7,9,11,13-eicosatetraenoic acid 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
Background The critical fatty acids Docosahexaenoic Acid (DHA) and Arachidonic Acid (AA) decline in preterm infants within the… 
Highly Cited
2013
Highly Cited
2013
Acute inflammation is an innate host-defense mechanism against invading pathogens and tissue injury. Neutralization of the… 
Highly Cited
2007
Highly Cited
2007
OBJECTIVE To evaluate the role of an antiinflammatory lipid mediator, lipoxin A4 (LXA4), in inflammatory arthritis, we measured… 
Review
2002
Review
2002
It is well appreciated that lipid-derived mediators play key roles in inflammation and many other physiologic responses where… 
Highly Cited
2000
Highly Cited
2000
Tissue eosinophilia prevention represents one of the primary targets to new anti-allergic therapies. As lipoxin A4 (LXA4) and… 
Highly Cited
1999
Highly Cited
1999
It is of wide interest to understand how opposing extracellular signals (positive or negative) are translated into intracellular… 
Highly Cited
1988
Highly Cited
1988
The present chapter summarizes our findings with lipoxins (LX) in spasmogenic assays and in the intact microvasculature of the…